Literature DB >> 28839960

Do we have enough evidence for adjuvant postoperative chemoradiation in esophageal cancer?

Po-Kuei Hsu1.   

Abstract

Entities:  

Year:  2017        PMID： 28839960      PMCID： PMC5542982          DOI： 10.21037/jtd.2017.06.49

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  9 in total

1.  Long-term efficacy of perioperative chemoradiotherapy on esophageal squamous cell carcinoma.

Authors:  Jin Lv; Xiu Feng Cao; Bin Zhu; Lv Ji; Lei Tao; Dong Dong Wang
Journal:  World J Gastroenterol       Date:  2010-04-07       Impact factor: 5.742

2.  Preoperative chemoradiotherapy for esophageal or junctional cancer.

Authors:  P van Hagen; M C C M Hulshof; J J B van Lanschot; E W Steyerberg; M I van Berge Henegouwen; B P L Wijnhoven; D J Richel; G A P Nieuwenhuijzen; G A P Hospers; J J Bonenkamp; M A Cuesta; R J B Blaisse; O R C Busch; F J W ten Kate; G-J Creemers; C J A Punt; J T M Plukker; H M W Verheul; E J Spillenaar Bilgen; H van Dekken; M J C van der Sangen; T Rozema; K Biermann; J C Beukema; A H M Piet; C M van Rij; J G Reinders; H W Tilanus; A van der Gaast
Journal:  N Engl J Med       Date:  2012-05-31       Impact factor: 91.245

3.  Chemoradiotherapy before and after surgery for locally advanced esophageal cancer: a SEER-Medicare analysis.

Authors:  Julian C Hong; James D Murphy; Samuel J Wang; Albert C Koong; Daniel T Chang
Journal:  Ann Surg Oncol       Date:  2013-06-26       Impact factor: 5.344

4.  The role of surgery and postoperative chemoradiation therapy in patients with lymph node positive esophageal carcinoma.

Authors:  E L Bédard; R I Inculet; R A Malthaner; E Brecevic; M Vincent; R Dar
Journal:  Cancer       Date:  2001-06-15       Impact factor: 6.860

5.  Mature results from a phase II trial of postoperative concurrent chemoradiotherapy for poor prognosis cancer of the esophagus and gastroesophageal junction.

Authors:  David J Adelstein; Thomas W Rice; Lisa A Rybicki; Jerrold P Saxton; Gregory M M Videtic; Sudish C Murthy; David P Mason; Cristina P Rodriguez; Denise I Ives
Journal:  J Thorac Oncol       Date:  2009-10       Impact factor: 15.609

6.  Pre- versus postoperative chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.

Authors:  Po-Kuei Hsu; Hui-Shan Chen; Chia-Chuan Liu; Chien-Sheng Huang; Chih-Cheng Hsieh; Han-Shui Hsu; Shiao-Chi Wu
Journal:  J Thorac Cardiovasc Surg       Date:  2017-03-21       Impact factor: 5.209

7.  Benefit of postoperative adjuvant chemoradiotherapy in locoregionally advanced esophageal carcinoma.

Authors:  Thomas W Rice; David J Adelstein; Mark A Chidel; Lisa A Rybicki; Malcolm M DeCamp; Sudish C Murthy; Eugene H Blackstone
Journal:  J Thorac Cardiovasc Surg       Date:  2003-11       Impact factor: 5.209

8.  A Propensity-matched Analysis Comparing Survival After Esophagectomy Followed by Adjuvant Chemoradiation to Surgery Alone for Esophageal Squamous Cell Carcinoma.

Authors:  Jwu-Yun Hwang; Hui-Shan Chen; Po-Kuei Hsu; Yin-Kai Chao; Bing-Yen Wang; Chien-Sheng Huang; Chia-Chuan Liu; Shiao-Chi Wu
Journal:  Ann Surg       Date:  2016-07       Impact factor: 12.969

9.  The Impact of Adjuvant Postoperative Radiation Therapy and Chemotherapy on Survival After Esophagectomy for Esophageal Carcinoma.

Authors:  Andrew T Wong; Meng Shao; Justin Rineer; Anna Lee; David Schwartz; David Schreiber
Journal:  Ann Surg       Date:  2017-06       Impact factor: 12.969
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.